BRPI0821895A2 - PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS - Google Patents
PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSISInfo
- Publication number
- BRPI0821895A2 BRPI0821895A2 BRPI0821895-1A2A BRPI0821895A BRPI0821895A2 BR PI0821895 A2 BRPI0821895 A2 BR PI0821895A2 BR PI0821895 A BRPI0821895 A BR PI0821895A BR PI0821895 A2 BRPI0821895 A2 BR PI0821895A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- symptoms
- disease
- prevention
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/004393 WO2009123595A1 (en) | 2008-04-04 | 2008-04-04 | Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0821895A2 true BRPI0821895A2 (en) | 2014-10-07 |
Family
ID=41135838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0821895-1A2A BRPI0821895A2 (en) | 2008-04-04 | 2008-04-04 | PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2262369A4 (en) |
JP (1) | JP2011516472A (en) |
KR (1) | KR20110009128A (en) |
CN (1) | CN102046011A (en) |
AU (1) | AU2008354007A1 (en) |
BR (1) | BRPI0821895A2 (en) |
CA (1) | CA2720390A1 (en) |
IL (1) | IL208386A0 (en) |
WO (1) | WO2009123595A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110056042A (en) * | 2009-11-20 | 2011-05-26 | 주식회사유한양행 | Nano particles for tumor-targeting and processes for the preparation thereof |
CL2012001399A1 (en) | 2009-12-03 | 2013-03-08 | Novartis Ag | Method to manufacture adjuvant for vaccine (oil / water emulsion with squalene, polysorbate 80 and sorbitan trioleate), which comprises (i) forming the first emulsion in a homogenizer from one container to another to form a second emulsion, (ii) and microfluidizing the first emulsion to form second emulsion. |
DK2343052T3 (en) * | 2009-12-03 | 2013-09-02 | Novartis Ag | HYDROPHIL FILTERING WHILE PREPARING VACCINE ADJUSTERS |
DE102009056871A1 (en) * | 2009-12-03 | 2011-06-22 | Novartis AG, 4056 | Vaccine adjuvants and improved methods of making the same |
ES2573710T3 (en) | 2009-12-03 | 2016-06-09 | Novartis Ag | Circulation of components during homogenization and microfluidization of emulsions |
AP3552A (en) | 2010-05-03 | 2016-01-18 | Teikoku Pharma Usa Inc | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
WO2013112249A1 (en) | 2012-01-24 | 2013-08-01 | University Of Southern California | Digital circuit power measurements using numerical analysis |
JO3685B1 (en) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | Non-aqueous taxane nanodispersion formulations and methods of using the same |
US10220095B2 (en) | 2013-03-15 | 2019-03-05 | Taiwan Liposome Company, Ltd | Controlled drug release liposome compositions and methods thereof |
US9693958B2 (en) * | 2013-03-15 | 2017-07-04 | Cureport, Inc. | Methods and devices for preparation of lipid nanoparticles |
US11172675B2 (en) * | 2014-12-22 | 2021-11-16 | Oro Agri Inc. | Nano particulate delivery system |
US10386395B1 (en) | 2015-06-03 | 2019-08-20 | University Of Southern California | Subcircuit physical level power monitoring technology for real-time hardware systems and simulators |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7387790B2 (en) * | 2001-06-15 | 2008-06-17 | Cornerstone Pharmaceuticals | Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
IL163808A0 (en) * | 2002-03-01 | 2005-12-18 | Yissum Res Dev Co | Self emulsifying drug delivery systems for poorly soluble drugs |
WO2004011478A2 (en) * | 2002-07-25 | 2004-02-05 | Micrologix Biotech Inc. | Anti-viral 7-deaza d-nucleosides and uses thereof |
US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
US20060257493A1 (en) * | 2005-04-28 | 2006-11-16 | Amiji Mansoor M | Nanoparticulate delivery systems for treating multi-drug resistance |
US20070148194A1 (en) * | 2005-11-29 | 2007-06-28 | Amiji Mansoor M | Novel nanoemulsion formulations |
-
2008
- 2008-04-04 EP EP08742550.0A patent/EP2262369A4/en not_active Withdrawn
- 2008-04-04 JP JP2011502906A patent/JP2011516472A/en active Pending
- 2008-04-04 AU AU2008354007A patent/AU2008354007A1/en not_active Abandoned
- 2008-04-04 KR KR1020107024777A patent/KR20110009128A/en not_active Application Discontinuation
- 2008-04-04 CN CN200880129433XA patent/CN102046011A/en active Pending
- 2008-04-04 WO PCT/US2008/004393 patent/WO2009123595A1/en active Application Filing
- 2008-04-04 BR BRPI0821895-1A2A patent/BRPI0821895A2/en not_active IP Right Cessation
- 2008-04-04 CA CA2720390A patent/CA2720390A1/en not_active Abandoned
-
2010
- 2010-10-03 IL IL208386A patent/IL208386A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2262369A4 (en) | 2013-05-29 |
AU2008354007A1 (en) | 2009-10-08 |
CA2720390A1 (en) | 2009-10-08 |
WO2009123595A1 (en) | 2009-10-08 |
EP2262369A1 (en) | 2010-12-22 |
KR20110009128A (en) | 2011-01-27 |
JP2011516472A (en) | 2011-05-26 |
IL208386A0 (en) | 2010-12-30 |
CN102046011A (en) | 2011-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0821895A2 (en) | PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A DISEASE, A CONDITION AND SYMPTOMS OF THE SAME IN HOT BLOOD ANIMALS, INCLUDING HUMAN BEINGS, METHOD FOR PREPARATION OF THE PHARMACEUTICAL COMPOSITION, METHOD DIAGNOSIS | |
BRPI1009860A2 (en) | compound, use thereof, pharmaceutical composition and method for the therapeutic treatment or prevention of disease in humans or animals | |
BRPI0822162A8 (en) | method for treating nail or nail bed disease and pharmaceutical composition for topical treatment of nail or nail bed disease. | |
BRPI0811436A2 (en) | COMPOUND, USE OF A COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR PAIN THERAPY IN A HOT BLOOD ANIMAL, SUPER ACTIVE BLADDER THERAPY IN A HOT BLOOD ANIMAL, AND TO PREPARE A COMPOUND. | |
BRPI1011220A2 (en) | pharmaceutical composition, methods of treating a disease or disorder, for the respiratory administration of two or more active agents, for the respiratory administration of a combination of active agents, and for preparing a suitable composition. | |
BRPI0911520A2 (en) | new therapeutic approaches for the treatment of alzheimer's disease and related diseases through angiogenesis modulation. | |
BR112013010665A2 (en) | system for treating a medical condition in humans or animals, method of treating a medical condition in humans or animals with one or more therapeutic agents, device for treating a medical condition in humans or animals, and catheter device for administering a fluid to a blood vessel | |
DK1915620T3 (en) | Diagnosis, treatment and contraception of vascular diseases using IL-1alpha autoantibodies | |
BRPI0717697A2 (en) | compound, pharmaceutical composition, use of the compound, method of treating a patient suffering from a pathological condition or disease and combination of products | |
BRPI0819916A2 (en) | Antigen binding protein, pharmaceutical composition, method for treating a human patient afflicted with a disease, antibody or fragment thereof, and antigen binding protein. | |
BRPI0810081A2 (en) | THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR BRAIN DISEASES | |
BRPI0922817A2 (en) | absorbent medical staff, in particular for removing wound fluids from human and / or animal body cavities and methods for their production | |
WO2012087742A3 (en) | Methods and compositions suitable for managing blood glucose in animals | |
BRPI0812384A2 (en) | TREATMENT, DIAGNOSTIC AND DISEASE TREATMENT METHODS ASSOCIATED WITH FGF21 | |
BRPI0909557A2 (en) | bandage set, reduced pressure treatment system, and system to assist in healing a wound in a patient. | |
BRPI0814957A2 (en) | COMPOUND, PRODUCT, PHARMACEUTICAL AGENT, METHOD FOR PROPHYLAXY OR TREATMENT OF A DISEASE, DISORDER OR CONDITION, AND USE OF THE COMPOUND. | |
WO2008149802A1 (en) | Anti-fatigue agent and oral composition each comprising andrographolide as active ingredient | |
BRPI1012051A2 (en) | "oral care composition, polymeric matrix film, and methods for preparing the film, and for treating an oral cavity disease or condition" | |
BRPI0918398A2 (en) | Method for diagnosing a physiological abnormality in a patient, System for diagnosing a physiological abnormality in a patient, Catheter and Device for diagnosing a physiological abnormality in a patient | |
BRPI0818841A2 (en) | Compounds for use in imaging, diagnosis and / or treatment of central nervous system or tumor disease | |
BR112015006656A8 (en) | compositions and methods for the treatment of heart failure in diabetic patients | |
BRPI0913854A2 (en) | compound, pharmaceutical composition, use of the compound, and, method for treating, preventing or alleviating a disease or disorder or condition of a living animal organism. | |
BRPI0612624A2 (en) | methods for treating vascular disease in a human, and for preventing and / or treating a thrombosis-induced disease or a thromboembolism-induced disease in a human, and use of a compound | |
BRPI0908837A2 (en) | Triaryl derivative, pharmaceutical composition, use of a triaryl derivative, and method for treating, preventing or relieving a disease, disorder or condition of a living animal body | |
ZA201106056B (en) | Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8,6 NA RPI 2343 DE 01/12/2015 |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2432 DE 15/08/2017. |